1L, first-line; IV, intravenous; PD, progressive disease; QxW, every x weeks.
1. Opdivo® (nivolumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb. 2. Yervoy® (ipilimumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb.